Reduction of CD38 in blast crisis cells may allow sufficient NAD+ supply for markedly increased SIRT1 expression in blast crisis CML [37]. The gene discussed is SIRT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.